
Next generation semen analysis products based on lensless computational microscopy coupled with advanced image processing, big data and machine learning approaches.
Market:
On average 20% of couples find difficulties conceiving within the first year of trying. In 40%-50% of these cases, male fertility issues are at the source of the problem. Fertility market globally is significant, reaching up to $40 billion per year.
Technology:
Lucendi Semen Performance Analytics is aimed to be a rapid (<2 minutes), simple-to-use, inexpensive, compact, lightweight, and portable platform for automated analysis of sperm characteristics, ideal for repeated and continual testing. All of these characteristics enable it to be applicable to a variety of monitoring/diagnostic needs for in-home, in-field and point-of-care testing.Advantages:
- Inexpensive, portable and lightweight
- Accurate and detailed semen characterization
- Automated analysis through machine learning
- Significantly larger field of view, better statistical analysis
- High throughput
Development Stage:
- Advanced Prototype
Patents Issued:
- Compact automated semen analysis platform using lens-free on-chip microscopy, U.S. Patent No. 8,842,901, 9/23/2014
Select Publications:
- Compact and Light-Weight Automated Semen Analysis Platform Using Lensfree on-Chip Microscopy | Analytical Chemistry
- High-throughput lensfree 3D tracking of human sperms reveals rare statistics of helical trajectories | Proceedings of the National Academy of Sciences (PNAS)
- Sperm Trajectories Form Chiral Ribbons | Scientific Reports
- High-throughput analysis of horse sperms’ 3D swimming patterns using computational on-chip imaging | Animal Reproduction Science
Contact:
Email: info@lucendi.orgPhone: 858-405-8319
Website: www.lucendi.org
Graduated in 2019
Graduated Companies
- Adaptix
- Aneeve
- Aneuvo
- Appia Bio
- Bluefin Foods
- CarbonBuilt
- Carbonics
- Charlot Biosciences
- CBD Research Institute
- Cellmic
- Concrete-AI
- Craytex
- CytoLumina
- DARTS Sciences
- Electronucleics
- EP Dynamics
- Ferrologix
- Horizon PV
- Inspira
- Inston
- InvVax
- Kelvi
- Keyssa
- Kythera Biopharmaceuticals
- Librede
- Lucendi
- Matrix Sensors, Inc.
- MAX BioPharma
- MediSens Wireless
- MicrobeDx
- Millibatt
- MyoGene Bio
- Myst Therapeutics
- Nammi Therapeutics
- NanoClear
- NanoElectronic Imaging
- NanoH₂O
- Nanopixel Technologies
- National Institute of Cannabinoid Research (NICR)
- Octant
- Omega Biosystems
- Orchard Therapeutics
- Polyradiant
- Qwixel Therapeutics
- Restore Technologies
- Sardona Therapeutics
- SELFA
- Sixal
- Spectradyne Particle Analysis
- Tempo Therapeutics
- TrueCath
- U-Defi
- Valerion Therapeutics
- Vivibaba
- Zenomics
- Back to Portfolio